George Tidmarsh, the Food and Drug Administration’s top drug regulator, will take on additional responsibilities on a temporary basis after the sudden departure of top official Vinay Prasad on Tuesday.
Tidmarsh has been named acting director of the FDA’s Center for Biologics Evaluation and Research, FDA Commissioner Marty Makary said in an email viewed by STAT. That’s one of the roles vacated by Prasad. Prasad was also the agency’s chief medical and scientific officer.
“The FDA was very fortunate to have Vinay’s expertise at CBER,” Makary wrote to CBER staff. “He implemented major reforms and designed new regulatory frameworks that will have an enduring impact.”
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
